Positron Emission Tomography (PET) is a medical imaging technology that is used to detect and diagnose medical conditions in the body. It is a type of scan that produces three-dimensional images of the body by measuring the distribution of radioactive tracers in the patient's body. PET scans have numerous medical applications. These scans are primarily used in the early detection of cancer, by detecting cancerous tumors before they have had a chance to grow and spread. They are also commonly used to diagnose a range of cardiovascular conditions, impacting the heart and blood vessels. In addition, they are used to detect and diagnose several neurological disorders as well as certain types of brain tumors. The underlying process of PET scans is based on the administration of small amounts of a radioactive tracer, such as fluorodeoxyglucose (FDG) to the patient. This tracer is composed of a carbohydrate component and a radioactive particle. The tracer is administered intravenously and is then absorbed by the tissues of the body, flowing through the bloodstream. Once the tracer has been absorbed, the patient is placed in position in the PET scanner and the images are generated. The images collected measure the radioactivity absorbed by the patient's body tissues, often by detection of gamma rays from the radiation emitted by the tracer. The images can be used to visualize and detect any abnormal growths in the body, such as tumors, and enable subsequent diagnosis and treatment. Overall, positon emissions tomography is an invaluable technology for detecting and diagnosing a number of medical conditions, ranging from cancer to cardiovascular and neurological disorders.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States